|
Market Closed -
NYSE
04:00:00 2026-09-04 pm EDT
|
5-day change | 1st Jan Change | ||
| 3.130 USD | +0.32% |
|
+0.64% | +13.82% |
| Aug. 19 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| Aug. 14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
Stock exchange
Quotes 5-day view: Perspective Therapeutics, Inc.
Delayed Quote NYSE
| 2026-08-31 | 2026-09-01 | 2026-09-02 | 2026-09-03 | 2026-09-04 | |
|---|---|---|---|---|---|
| Last | $3.160 | $3.100 | $3.100 | $3.120 | $3.130 |
| Volume | 910,730 | 705,838 | 864,638 | 931,703 | 1,365,189 |
| Change | +1.61% | -1.90% | 0.00% | +0.65% | +0.32% |
| Opening | $3.110 | $3.160 | $3.100 | $3.090 | $3.070 |
| High | $3.180 | $3.165 | $3.235 | $3.140 | $3.180 |
| Low | $3.080 | $3.070 | $3.025 | $3.030 | $3.025 |
Performance
| 1 day | +0.32% | ||
| 1 week | +0.64% | ||
| Current month | -0.95% | ||
| 1 month | +5.39% | ||
| 3 months | +3.30% | ||
| 6 months | -37.02% | ||
| Current year | +13.82% | ||
| 1 year | -9.54% | ||
| 3 years | -20.68% | ||
| 5 years | -54.41% | ||
| 10 years | -57.71% |
Volumes
marketsDaily volume
1,365,189
Estimated daily volume
1,365,189
Avg. Volume 20 sessions
982,300
Daily volume ratio
1.39
Avg. Volume 20 sessions USD
3,074,599
Record volume 1
80,199,886
Record volume 2
25,910,000
Record volume 3
22,880,724
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
357,294,705
Net sales (USD)
884,000
Number of employees
165
Sales / Employee (USD)
5,358
Free-Float
89.27 %
Free-Float capitalization (USD)
318,943,876
Average Daily Capital Traded
0.86%
Indicators
Moving average 5 days
3.122
Moving average 20 days
3.178
Moving average 50 days
3.133
Moving average 100 days
3.415
Price spread / (MMA5)
-0.26%
Price spread / (MMA20)
+1.55%
Price spread / (MMA50)
+0.11%
Price spread / (MMA100)
+9.11%
STIM
RSI 9 days
47.31
RSI 14 days
48.75
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.32% | +0.64% | -9.54% | -20.68% | 357M | |
| -1.16% | -3.97% | -2.91% | +13.00% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +527.30% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +22.37% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +77.49% | 40.73B | |
| -0.96% | -2.31% | +15.75% | +45.41% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +120.75% | 16.5B | |
| -1.54% | -1.05% | +12.16% | +29.80% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.12% | 13.77B | |
| Average | -0.83% | +0.50% | +64.32% | +95.17% | 27.54B | |
| Weighted average by Cap. | -0.95% | +0.05% | +88.82% | +128.22% |
Historical Quotes: Perspective Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
1.YGk9r30eqX60xrzWl0PDK1P6wwFI0-XHjCqGzp6pVe8.PwxN_Cso_UbkpYSm5Hq3aTrKsjQmhLGB4Fnv-a3HALg5IQTlK0bGPde-_Q
| Date | Price | Volume | Total |
|---|---|---|---|
| 04:00:00 pm | 3.130 | 90,468 | 1,221,696 |
| 03:59:59 pm | 3.140 | 312 | 1,131,228 |
| 03:59:59 pm | 3.140 | 100 | 1,130,916 |
| 03:59:59 pm | 3.140 | 135 | 1,130,816 |
| 03:59:59 pm | 3.140 | 300 | 1,130,681 |
| 03:59:59 pm | 3.140 | 400 | 1,130,381 |
| 03:59:59 pm | 3.140 | 800 | 1,129,981 |
| 03:59:59 pm | 3.150 | 122 | 1,129,181 |
| 03:59:59 pm | 3.145 | 146 | 1,129,059 |
Price Extremes
| 1 week | 3.02 |  | 3.24 |
| 1 month | 2.94 | | 3.56 |
| Current year | 2.25 | | 6.16 |
| 1 year | 1.96 | | 6.16 |
| 3 years | 1.6 | | 19.05 |
| 5 years | 1.6 | | 19.05 |
| 10 years | 1.6 | | 28.1 |
Monthly variations
Annual variations
| 2026 | +13.82% | ||
| 2025 | -13.79% | ||
| 2024 | -20.65% | ||
| 2023 | +62.69% | ||
| 2022 | -36.28% | ||
| 2021 | -13.82% | ||
| 2020 | -27.93% | ||
| 2019 | +108.13% | ||
| 2018 | -24.87% | ||
| 2017 | -31.16% | ||
| 2016 | -38.13% | ||
| 2015 | -35.79% | ||
| 2014 | +192.00% | ||
| 2013 | -35.90% | ||
| 2012 | +18.18% | ||
| 2011 | -41.59% | ||
| 2010 | +26.98% | ||
| 2009 | +344.95% | ||
| 2008 | -90.05% | ||
| 2007 | -58.98% | ||
| 2006 | -32.41% | ||
| 2005 | +625.00% |
- Stock Market
- Stocks
- CATX Stock
- Quotes Perspective Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
